In a stunning display of confidence—some might call it audacity—a CRO executive walked into my office and flatly told my academic research group that we were completely unqualified to lead a major clinical trial for a groundbreaking biotech drug. It was a brazen attempt to take over the contract for Quintiles, showcasing the bare-knuckle nature of pharmaceutical research negotiations.
This incident serves as a stark reminder that the most confident approach isn't always the right one, especially when partnership and collaboration are essential. Sometimes, the boldest sales pitch can backfire, revealing more about the pitchman than the product.